Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China

被引:1
|
作者
Liu, Yinfeng [1 ]
Zheng, Jie [1 ]
Xu, Yue [2 ]
Lv, Ji [1 ]
Wu, Zizheng [1 ]
Feng, Kai [1 ]
Liu, Jiani [1 ]
Yan, Weitao [1 ]
Wei, Liguang [1 ]
Zhao, Jiangman [2 ]
Jiang, Lisha [2 ]
Han, Meng [1 ]
机构
[1] First Hosp Qinhuangdao, Breast Dis Diag & Treatment Ctr, Qinhuangdao, Hebei, Peoples R China
[2] Shanghai Biotecan Pharmaceut Co Ltd, Shanghai, Peoples R China
关键词
breast cancer; multi-gene panels; rare genetic variants; in silico protein modeling; pathogenic/likely pathogenic variants; GERMLINE MUTATIONS; ASSOCIATION; BRCA1;
D O I
10.3389/fgene.2023.1271710
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset patterns and genetic backgrounds. This study aims to examine the genetic landscape and clinical implications of rare mutations in Chinese breast cancer patients.Methods: Clinical data from 253 patients, including sporadic and familial cases, were analyzed. Comprehensive genomic profiling was performed, categorizing identified rare variants according to the American College of Medical Genetics (ACMG) guidelines. In silico protein modeling was used to analyze potentially pathogenic variants' impact on protein structure and function.Results: We detected 421 rare variants across patients. The most frequently mutated genes were ALK (22.2%), BARD1 (15.6%), and BRCA2 (15.0%). ACMG classification identified 7% of patients harboring Pathogenic/Likely Pathogenic (P/LP) variants, with one case displaying a pathogenic BRCA1 mutation linked to triple-negative breast cancer (TNBC). Also identified were two pathogenic MUTYH variants, previously associated with colon cancer but increasingly implicated in breast cancer. Variants of uncertain significance (VUS) were identified in 112 patients, with PTEN c.C804A showing the highest frequency. The role of these variants in sporadic breast cancer oncogenesis was suggested. In-depth exploration of previously unreported variants led to the identification of three potential pathogenic variants: ATM c.C8573T, MSH3 c.A2723T, and CDKN1C c.C221T. Their predicted impact on protein structure and stability suggests a functional role in cancer development.Conclusion: This study reveals a comprehensive overview of the genetic variants landscape in Chinese breast cancer patients, highlighting the prevalence and potential implications of rare variants. We emphasize the value of comprehensive genomic profiling in breast cancer management and the necessity of continuous research into understanding the functional impacts of these variants.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants
    Mezina, Anya
    Philips, Neil
    Bogus, Zoe
    Erez, Noam
    Xiao, Rui
    Fan, Ruoming
    Olthoff, Kim M.
    Reddy, K. Rajender
    Samadder, N. Jewel
    Nielsen, Sarah M.
    Hatchell, Kathryn E.
    Esplin, Edward D.
    Rustgi, Anil K.
    Katona, Bryson W.
    Hoteit, Maarouf A.
    Nathanson, Katherine L.
    Wangensteen, Kirk J.
    JCO PRECISION ONCOLOGY, 2021, 5 : 988 - 1000
  • [32] Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer
    Hirasawa, Akira
    Imoto, Issei
    Naruto, Takuya
    Akahane, Tomoko
    Yamagami, Wataru
    Nomura, Hiroyuki
    Masuda, Kiyoshi
    Susumu, Nobuyuki
    Tsuda, Hitoshi
    Aoki, Daisuke
    ONCOTARGET, 2017, 8 (68) : 112258 - 112267
  • [33] Clinical management of high-risk breast cancer patients with variants of uncertain significance in the era of multigene panel testing
    Chang, Jenny
    Yoo, June
    Seng, Sirivan
    Esquivel, Pamela
    Lum, Sharon
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 62 - 63
  • [34] EClinical Multigene Panel Testing Identifies Racial/Ethnic and Sex Differences in Germline Pathogenic Variants among Patients with EarlyOnset Colorectal Cancer
    Holowatyj, Andreana N.
    Keller, Samantha R.
    Seagle, Hannah
    Tavtigian, Sean V.
    Horton, Carolyn
    JOURNAL OF WOMENS HEALTH, 2023, 32 (11) : A10 - A10
  • [35] Genetic Testing for Breast Cancer in the Era of Multigene Panels: Can We Make an Impact on Population Health?
    Ginsburg, Ophira
    Brennan, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (28) : 2817 - +
  • [36] Prevalence and Distribution of Unexpected Actionable Germline Pathogenic Variants Identified on Broad-Based Multigene Panel Testing Among Patients With Cancer
    Landry, Kara K.
    Desarno, Michael J.
    Kipnis, Lindsay
    Barquet Ramos, Farid
    Breen, Katelyn M.
    Patton, Kaleigh
    Morrissette, Audrey
    Buehler, Ryan M.
    Ukaegbu, Chinedu
    Rohanizadegan, Mersedeh
    Yurgelun, Matthew B.
    Syngal, Sapna
    Rana, Huma Q.
    Garber, Judy E.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [37] Different CNVs account for 10.4% of pathogenic variants in 1418 patients referred for hereditary breast cancer testing
    Tsoulos, Nikolaos
    Agiannitopoulos, Konstantinos
    Pepe, Georgia
    Papadopoulou, Eirini
    Tsaousis, Georgios N.
    Apostolopoulou, Despina
    Meintani, Angeliki
    Venizelos, Vassileios
    Markopoulos, Christos
    Iosifidou, Rodoniki
    Karageorgopoulou, Sofia
    Christodoulou, Christos
    Natsiopoulos, Ioannis
    Papazisis, Konstantinos
    Vasilaki-Antonatou, Maria
    Kabletsas, Eleftherios
    Psyrri, Amanta
    Giassas, Stylianos
    Ziogas, Dimitrios
    Lalla, Efthalia
    Koumarianou, Anna
    Papadimitriou, Christos
    Ozmen, Vahit
    Tansan, Sualp
    Kaban, Kerim
    Ozatli, Tahsin
    Eniu, Dan Tudor
    Chiorean, Angelica
    Blidaru, Alexandru
    Nasioulas, George
    CANCER RESEARCH, 2022, 82 (04)
  • [38] Genetic Variants in Patients With a Family History of Pancreatic Cancer Impact of Multigene Panel Testing
    Zhu, Huili
    Welinsky, Sara
    Soper, Emily R.
    Brown, Karen L.
    Abul-Husn, Noura S.
    Lucas, Aimee L.
    PANCREAS, 2021, 50 (04) : 602 - 606
  • [39] Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer
    Heald, Brandie
    Mokhtary, Sara
    Nielsen, Sarah M.
    Rojahn, Susan
    Yang, Shan
    Michalski, Scott T.
    Esplin, Edward D.
    GYNECOLOGIC ONCOLOGY, 2022, 166 (02) : 344 - 350
  • [40] Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
    Hu, Chunling
    LaDuca, Holly
    Shimelis, Hermela
    Polley, Eric C.
    Lilyquist, Jenna
    Hart, Steven N.
    Na, Jie
    Thomas, Abigail
    Lee, Kun Y.
    Davis, Brigette Tippin
    Black, Mary Helen
    Pesaran, Tina
    Goldgar, David E.
    Dolinsky, Jill S.
    Couch, Fergus J.
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 28